ADMA Levels and Mortality in Sepsis
Author Information
Author(s): Davis Joshua S., Darcy Christabelle J., Yeo Tsin W., Jones Catherine, McNeil Yvette R., Stephens Dianne P., Celermajer David S., Anstey Nicholas M.
Primary Institution: Menzies School of Health Research and Charles Darwin University
Hypothesis
Plasma L-arginine: ADMA ratio would be decreased in sepsis, in proportion to disease severity, and would correlate with reactive hyperaemia peripheral arterial tonometry (RH-PAT) index.
Conclusion
Increased plasma ADMA is associated with higher mortality in sepsis patients.
Supporting Evidence
- Baseline plasma L-arginine: ADMA ratio was significantly lower in sepsis patients than in controls.
- Baseline plasma ADMA was independently associated with 28-day mortality.
- Increase in ADMA over time correlated with increase in organ failure.
Takeaway
This study found that higher levels of a substance called ADMA in the blood can predict if someone with sepsis might not survive.
Methodology
A prospective longitudinal study measuring plasma ADMA and L-arginine concentrations in sepsis patients and controls.
Limitations
Not all sepsis patients were followed up on day 2-4 due to hospital discharge, which may underestimate improvement in microvascular and organ function.
Participant Demographics
67 patients with acute sepsis and 31 controls, well-matched in age and sex.
Statistical Information
P-Value
p<0.0001
Confidence Interval
[2.2–195.0]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website